Osaic Holdings
REVB icon

Osaic Holdings’s Revelation Biosciences REVB Stock Holding History

Osaic Holdings’s Portfolio REVB Stock Details REVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2
Closed -$822 – 7587
2024
Q1 		$822 Buy
+2
New +$2.41K ﹤0.01% 6724

Other funds holding REVB

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PIS
POM Investment Strategies Raleigh, North Carolina $88.3M AUM 15.23% 1-Year Est. Return

Osaic Holdings's REVB Position: Q2 2024 in Review

Osaic Holdings sold out of Revelation Biosciences (REVB) in Q2 2024, closing a stake of 2 shares — an estimated $822 sold.

Osaic Holdings first reported a position in REVB in Q1 2024 and held it in 1 quarter. The position peaked at $822 in Q1 2024. 4 funds tracked by Wall St. Rank hold REVB as of Q2 2024.

  • Osaic Holdings reported no remaining Revelation Biosciences position as of Q2 2024 after selling out during the quarter.
  • Osaic Holdings sold 2 Revelation Biosciences shares in Q2 2024, an estimated $822.
  • Osaic Holdings first reported a position in Revelation Biosciences in Q1 2024 and held it in 1 quarter.
  • Osaic Holdings's Revelation Biosciences position peaked at $822 in Q1 2024.
  • 4 funds tracked by Wall St. Rank held Revelation Biosciences as of Q2 2024.

Based on Osaic Holdings's 13F filing for Q2 2024, filed 13 Aug 2024.